ARTICLE SUMMARY:
Medtech companies have long had a complicated relationship with group purchasing organizations (GPOs), especially with the national GPOs. GPOs offer opportunity for greater market coverage and efficient contracting, both of which benefit medtechs and their provider customers. At the same time, there has always been pervasive and not-so-subtle grumbling about the market influence that GPOs can wield and the level of reciprocal value realized by medtech companies.
By Ken Graves, Kevin Grabenstatter, and Jonas Funk, LEK Consulting.
Medtech companies have long had a complicated relationship with group purchasing organizations (GPOs), especially with the national GPOs. GPOs offer the opportunity for greater market coverage and efficient contracting, both of which benefit medtechs and their provider customers.
